











































Valuation and Modeling of EQ-5D-5L Health
States Using a Hybrid Approach
Juan M. Ramos-Goñi, MSc,*wz Jose L. Pinto-Prades, PhD,y Mark Oppe, PhD,z
Juan M. Cabasés, PhD,8 Pedro Serrano-Aguilar, PhD,*w and Oliver Rivero-Arias, DPhilwz
Background: The EQ-5D instrument is the most widely used pref-
erence-based health-related quality of life questionnaire in cost-ef-
fectiveness analysis of health care technologies. Recently, a version
called EQ-5D-5L with 5 levels on each dimension was developed.
This manuscript explores the performance of a hybrid approach for
the modeling of EQ-5D-5L valuation data.
Methods: Two elicitation techniques, the composite time trade-off,
and discrete choice experiments, were applied to a sample of the
Spanish population (n = 1000) using a computer-based ques-
tionnaire. The sampling process consisted of 2 stages: stratified
sampling of geographic area, followed by systematic sampling in
each area. A hybrid regression model combining composite time
trade-off and discrete choice data was used to estimate the potential
value sets using main effects as starting point. The comparison
between the models was performed using the criteria of logical
consistency, goodness of fit, and parsimony.
Results: Twenty-seven participants from the 1000 were removed
following the exclusion criteria. The best-fitted model included 2
significant interaction terms but resulted in marginal improvements
in model fit compared to the main effects model. We therefore
selected the model results with main effects as a potential value set
for this methodological study, based on the parsimony criteria. The
results showed that the main effects hybrid model was consistent,
with a range of utility values between 1 and 0.224.
Conclusion: This paper shows the feasibility of using a hybrid
approach to estimate a value set for EQ-5D-5L valuation data.
Key Words: utility theory, quality of life, maximum likelihood
estimation, time trade-off, discrete choice experiment
(Med Care 2017;55: e51–e58)
The EQ-5D instrument is the most widely used preference-based health-related quality of life questionnaire in cost-
effectiveness analysis. Reimbursement agencies such as the
UK National Institute for Health and Care Excellence
(NICE) recommend the use of the EQ-5D in submissions to
the institute and this partly explains the spread use of the
instrument in applied studies.1
The original EQ-5D (EQ-5D-3L) is a questionnaire
with 5 dimensions (mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression) and 3 levels in each
dimension (no problems, some problems, and extreme
problems).2 Extensive research supports the use of the in-
strument in many disease areas but recent studies have
shown ceiling effects issues, particularly in general pop-
ulation samples.3,4 In response to this, the EuroQol Group
proposed a new version of the instrument: the EQ-5D-5L.
This new version increased the number of severity levels
from 3 to 5 (no problems, slight, moderate, severe, and un-
able or extreme) describing 3125 (55) possible health states.3
Each health state is usually represented using a 5-digit
number (profile) where 11111 indicates perfect health and
55555 the worst health state or pits state.
Available EQ-5D-3L value sets cannot be used directly
with 5-level version responses. As a temporary solution, an
interim scoring algorithm needs to be used.5 Therefore, new
valuation studies are necessary to obtain preferences from
the general public for EQ-5D-5L health states. The EuroQol
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Group has developed a valuation protocol to elicit prefer-
ences after a series of pilot studies conducted by research
teams worldwide.6 A group of researchers based in Spain,
the UK, and the Netherlands, has been one of the first teams
in implementing this protocol. This manuscript explores the
feasibility of a hybrid method to estimate a potential value
set for EQ-5D-5L valuation data.
METHODS
Protocol
The results obtained from the pilot studies6 informed
the standardized protocol for EQ-5D-5L value sets used in
this study.7 The interview process described in the protocol
has 5 sections. First, a general welcome and an introduction
to the research were given. Next, respondents were asked to
provide background information, including their own health
using the EQ-5D-5L, age, sex, and experience with illness.
This was followed by the composite time trade-off (C-TTO)
task, which was administered after giving an explanation of
the task, and included 10 EQ-5D-5L C-TTO valuations. The
next part was a discrete choice (DC) experiment, which
consisted of 7 paired comparisons. Finally, there was a
general thank you and goodbye. After each block of tasks (C-
TTO and DC experiments) and at the end of the interview,
participants were given the opportunity to clarify whether
they found difficulties completing the tasks and the overall
survey. The EuroQol Group developed the online system to




The traditional time trade-off (TTO) has been widely
used in the EQ-5D-3L valuation studies conducted so far and
it is appropriate to value health states considered better than
dead.8,9 However, using the traditional TTO method for
states worse than dead gives negative values that are nor-
mally transformed to be bounded to 1, which has been
criticized in the literature.10 Other TTO alternatives to
evaluate health states were therefore assessed during the
EuroQol pilot studies including lead and lag time.11,12 In the
former, additional trading time is included before the health
state, whereas in the latter, trading time is included after the
health state to be valued. The pilot studies looked at the
potential of using these methods in practice and concluded
that the protocol should include a composite TTO method.
This composite approach involved the use of the tra-
ditional TTO approach for states better than dead and lead
time TTO for states worse than dead in a single task.13 For
the lead time TTO, 10 years lead time and 10 years in the
state were used. This lead time method produces a minimum
value of 1 and no transformation of negative values is
needed. The iterative process used in the original UK valu-
ation exercise8 was adapted to be used in the C-TTO task.
The C-TTO design included 86 health states selected using
Monte Carlo simulation. The health states were distributed
over 10 blocks and each block contained 1 very mild state
(1 dimension at level 2, the remaining dimensions at level 1),
the pits state 55555, and a balanced set of intermediate states.
The EQ-VT randomly assigned respondents to one of the
blocks and presented the states in random order.
DC Experiment
The use of DC experiments for health state valuation
has received recent attention in the literature.14,15 Modeling
ordinal data follows the theoretical foundations of random
utility theory.16 Values obtained with DC models have been
shown to have patterns similar to those obtained with TTO
models.17 The values obtained from DC models are ex-
pressed on an arbitrary scale and need to be rescaled on the
dead (0) full health (1) scale.17,18 Using DC experiments was
also piloted and the results suggested that collecting such
information could provide additional useful information to
the C-TTO data. Hence, a DC experiment was included as
part of the protocol. The DC experiment design included 196
pairs divided in 28 blocks with similar severity representa-
tion identified using Bayesian design.19 The EQ-VT ran-
domly assigned respondents to one of the blocks, presented
the pairs in random order, and randomized the location of the
states within the pair (ie, left and right).
Sampling and Data Collection
Our power calculations estimated that to obtain a 0.01
SE of the observed mean C-TTO, we needed 9735 C-TTO
responses. We therefore recruited 1000 participants that after
completing the valuations tasks provided 10,000 C-TTO and
7000 DC responses to estimate the models.
A 2-stage sampling strategy was designed to obtain a
representative sample of the Spanish population. In a first
stage, we stratified geographically by Spanish provinces,
whereas in a second stage we systematically sample in-
dividuals from a panel until an accurate age and sex dis-
tribution for that province was achieved. We contracted an
independent market research company, which identified re-
spondents and arranged interviews at convenient places. In-
terviews were conducted face-to-face during June and July
2012 by 33 trained interviewers. Respondents did not receive
payment for participating in the survey. A different market
research company was contracted to call a random sub-
sample of 15% of respondents as quality control of the
process.
Statistical Analyses
Descriptive statistics were used to summarize re-
spondent’s characteristics and responses to the C-TTO and
DC experiments.
Two sources of data were available to estimate the EQ-
5D-5L value set: C-TTO and DC data. To maximize the use
of the available data, we implemented a hybrid modeling
approach that made use of both C-TTO and DC data to es-
timate the potential value sets. This hybrid method estimated
a unique set of coefficients from a likelihood function ob-
tained multiplying the likelihood functions of a normal dis-
tribution for the C-TTO data by the likelihood function
of a conditional logit distribution for DC data.20 As the co-
efficients estimated from a conditional logit are expressed on
a latent arbitrary utility scale, we used a rescaled parameter
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y, which assumes that the C-TTO model coefficients are
proportional to DC model coefficients. See the Appendix for
a full description and analytical derivation of the hybrid
method. This method combines the utility values elicited in
the C-TTO for the 86 health states with utility values elicited
in the DC experiment for 196 pairs of states. The dependent
variable in the C-TTO part of the model was defined as
1 minus the C-TTO observed values for a given health state
to indicate disutility and therefore coefficients expressed
utility decrements. In the DC part of the model, the depen-
dent variable was a binary outcome 0/1 indicating the re-
spondent’s choice for each pair of EQ-5D-5L states. We used
cluster estimation to acknowledge that for each participant
included in the models, 10 C-TTO and 7 DC responses were
available.
We also present models to estimate C-TTO and DC data
separately, to illustrate how the hybrid model combined both
types of data. We analyzed C-TTO data using a linear re-
gression model assuming normal distribution in its errors, as it
is the C-TTO part of hybrid model. We analyzed DC data
using the standard econometric method for ordinal data con-
ditional logit regression.16 To make model coefficients com-
parable, we rescaled the DC model coefficients using the same
rescaling parameter y that was estimated in the hybrid model.
We started exploring the hybrid main effects with a 20-
parameter model consisting of 4 dummies for each EQ-5D-
5L dimensions using level 1 as the reference. We constructed
dummies to represent the additional utility decrement of
moving from one level to another. For instance for the mo-
bility dimension we created 4 dummies MO1 to MO4 and the
coefficient associated to MO1 indicated the utility decrement
of moving from no problems (level 1) to slight problems
(level 2), MO2 the additional utility decrement of moving
from slight (level 2) to moderate (level 3) problems, and so
on. Therefore, the overall decrement of moving from no to
moderate problems could be calculated as the sum of the
coefficients of MO1 plus MO2. The same set of dummy
variables was defined for each of the remaining dimensions:
self-care (SC), usual activities (UA), pain/discomfort (PD),
and anxiety/depression (AD). We also estimated the model
using the definition of dummies implemented in most pre-
vious EQ-5D-3L valuation exercises21 and such analyses are
available from the authors upon request.
Our starting point for the selection of additional co-
variates for the models was the US valuation study.9 Several
variables were defined. For example, D1 as the number of
dimensions at levels 2, 3, 4, or 5 beyond the first; IJ as the
number of dimensions at level J beyond the first; K45 as the
number of dimensions at level 4 or 5, and others. Squared of
all terms were also introduced to assess nonlinear effects on
the dependent variable. We included all terms first, and use a
stepwise approach removing nonsignificant terms and en-
suring model consistency.
Exclusion Criteria and Interviewer Assessment
We excluded observations using the following 2 cri-
teria: (1) respondents with a positive slope on a regression
between his/her values and the severity of the health states
indicating that the participant provided higher utility values
for poorer health states on average; and (2) respondents who
valued all states equal to death.
We used the Kruskal-Wallis test to assess the differ-
ences among mean values by interviewer in the C-TTO
responses. We further assess this including dummies that
identified interviewers in the main effects model and using
an F test among the dummy coefficients.
Evaluation of Model Performance
We evaluated model performance using (1) logical
consistency of parameters; (2) goodness of fit; and (3) parsi-
mony. Estimated coefficients are said to be logically consistent
if magnitude values from logically worse health states are
lower than those from logically better health states. In our
estimated results this is translated to all main effects co-
efficients being positive. Goodness of fit was assessed using
the Akaike (AIC) and the Bayesian information criteria (BIC).
Finally, the principle of parsimony stated that if competing
models were similar in logical consistency and goodness of fit,
the model with fewer parameters was preferred. These 3 cri-
teria were used to compare different hybrid model specifica-
tions using different interaction terms. However, prediction
accuracy evaluated using mean square error or mean absolute
error are not appropriate measures in this case, given the lack
of an appropriate counterfactual for hybrid model predictions.
We present the results of the regression with the main
effects and the best-fitted model with significant terms.
Statistical analysis and regression modeling were conducted
in Stata MP 11.22 The hybrid model was not available in any
standard package and was programmed in Stata specifically
for this study.
Comparison With EQ-5D-3L Value Set
We calculated and compared predictions for the 3125
health states using the final selected EQ-5D-5L value set and
the interim solution to calculate EQ-5D-3L values5 presented
for a selected set of health states covering mild, moderate,
and severe states. In addition, we compared the kernel den-
sity functions for the index values of the 243 states of the
Spanish EQ-5D-3L value set23 and for the 3125 states of the
final selected EQ-5D-5L value set.
RESULTS
Descriptive Statistics
Twenty-seven participants from the 1000 were re-
moved following the exclusion criteria: 18 respondents with
a positive slope on a regression between his/her values and
the severity of the health states and 9 respondents who val-
ued all states equal to death. Overall the excluded ob-
servations were older with no studies or primary school
studies than the estimation sample (Table 1). The estimation
sample was similar in the distribution of employment status;
mean age and sex distribution than Spanish population, but
the estimation sample had a larger number of respondents in
age group 25–34 and fewer participants over 75 (Table 1).
The self-reported health using the EQ-5D-5L of respondents
showed that 18.90% reported problems in usual activities
and 30.8% reported problems in anxiety or depression
Medical Care  Volume 55, Number 7, July 2017 Valuation and Modeling of EQ-5D-5L Health States
Copyright r 2014 The Author(s). Published by Wolters Kluwer Health, Inc. www.lww-medicalcare.com | e53







(n=973) Spanish General Population (%)*
Age [mean (SD)] 49.26 (18.2) 43.62 (17.2) 40.2 (NA)
Age groups
18–24 3 (11.2) 114 (11.7) 9.0
25–34 4 (14.8) 270 (27.8) 18.3
35–44 5 (18.5) 170 (17.5) 19.6
45–54 5 (18.5) 148 (15.2) 17.9
55–64 4 (14.8) 111 (11.4) 13.5
65–74 2 (7.4) 108 (11.1) 10.2
75+ 4 (14.8) 52 (5.3) 11.0
Sex
Male 12 (44.4) 463 (47.6) 49.3
Female 15 (55.6) 510 (52.4) 50.7
Employment status
Housewife/house husband 1 (3.7) 70 (7.2) 10.51
Employed or freelance 11 (40.8) 529 (54.4) 44.98
Student 2 (7.4) 89 (9.1) 6.33
Retired 8 (29.6) 132 (13.6) 20.12
Unemployed 5 (18.5) 139 (14.3) 15.01
Disabled 0 (0) 8 (0.8) 3.03
Missing — 6 (0.6) —
Education
Higher education 10 (37.0) 314 (32.47) 17.70
High school 2 (7.4) 374 (38.68) 53.90
Primary school 10 (37.0) 234 (24.20) 26.30
No studies 5 (18.5) 45 (4.65) 2.10
Missing — 6 (0.6)
Experience with illness
Personal (%yes) 4 (14.8) 140 (14.4) NA
Relatives (%yes) 17 (62.96) 616 (63.3) NA
Other (%yes) 9 (33.3) 338 (34.7) NA
Self-reported EQ-5D-5L
Mobility
No problems 22 (81.48) 864 (88.80) 86.1
Slight problems 4 (14.81) 69 (7.09) 6.1
Moderate problems 1 (3.70) 32 (3.29) 4.7
Severe problems 0 (0) 7 (0.72) 2.4
Unable/extreme problems 0 (0) 1 (0.10) 0.8
Self-care
No problems 24 (88.89) 933 (95.89) 93.9
Slight problems 2 (7.41) 30 (3.08) 2.5
Moderate problems 1 (3.70) 9 (0.92) 1.7
Severe problems 0 (0) 1 (0.10) 0.9
Unable/extreme problems 0 (0) 0 (0) 1.0
Usual activities
No problems 22 (81.48) 891 (91.57) 89.2
Slight problems 3 (11.11) 57 (5.86) 4.7
Moderate problems 2 (7.41) 20 (2.06) 3.2
Severe problems 0 (0) 4 (0.41) 1.5
Unable/extreme problems 0 (0) 1 (0.10) 1.4
Pain
No problems 20 (74.07) 772 (79.34) 75.2
Slight problems 5 (18.52) 149 (15.31) 12.3
Moderate problems 1 (3.70) 37 (3.80) 8.7
Severe problems 0 (0) 10 (1.03) 3.5
Unable/extreme problems 1 (3.70) 5 (0.51) 0.4
Anxiety/depression
No problems 15 (55.56) 673 (69.17) 85.4
Slight problems 8 (29.63) 214 (21.99) 8.4
Moderate problems 2 (7.41) 71 (7.30) 4.2
Severe problems 1 (3.70) 15 (1.54) 1.6
Unable/extreme problems 1 (3.70) 0 (0) 0.4
*Data extracted from the 2012–2013 National Spanish Health Survey.
NA indicates not available.
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dimension (Table 1). For the remaining dimensions, pro-
portions of respondents with problems were <10% (Table 1).
The outcome of the quality control reported no in-
cidences, but we observed significant differences between
interviewers in the valuations obtained with Kruskal-Wallis
(P < 0.0001) and F tests (P < 0.0001).
We report further descriptive information about the
C-TTO and the DC data in the online supplemental digital
content (Tables 1 and 2 and SDC Figures 1 and 2, Supplemental
Digital Content, http://links.lww.com/MLR/A839).
Modeling Results
The hybrid model with main effects was a consistent
model predicting utilities with a range between 1 and 0.224
(Table 2). Both, the C-TTO and the DC models derived
logical inconsistencies. It is shown how the hybrid model
corrects the inconsistencies in the C-TTO model by using DC
information and the DC model inconsistencies with C-TTO
information. As described in the Appendix, the log likelihood
in the hybrid model was approximately the sum of the log
likehood of both C-TTO and DC models separately.
After exploring many interactions terms, the best-fitted
estimation model we found was using the interaction terms
D12 and K452 (Table 3). The constant term of this model was
suppressed as the D12 term captures the effect of the con-
stant. The reduction of the hybrid log likehood estimation for
those terms inclusion only reduces the AIC and BIC by
0.4%. About 3/4 of this reduction was produced by a re-
duction in the C-TTO part of the model.
The main effects hybrid model produced a wider range
of utility values at the upper and lower end of the scale
compared to the hybrid model including the terms D12 and
K452 (Table 4). Given that the improvement in goodness of
fit between the main effects and the best-fitted model was
marginal (0.4%), we have selected the estimation results
from the hybrid model with main effects as the value set for
this methodological study based on the parsimony criteria.
The probability density functions of the Spanish
EQ-5D-3L value set and the EQ-5D-5L value set presented
here (Fig. 1) show a symmetric distribution for EQ-5D-5L,
whereas the EQ-5D-3L has a bimodal distribution. The
proportion of states considered worse than death is lower in
the EQ-5D-5L value set.
DISCUSSION
In this manuscript we have reported the performance of a
hybrid approach to estimate a value set for the EQ-5D-5L
questionnaire. The choice of the hybrid approach is based on
the assumption that subjects have a unique utility function that
generates both the sets of responses. If utilities were the same
in the C-TTO and DC methods there would be no need of
combining them except for having more precise estimates. Our
hypothesis is that this disparity is related to the choice versus
matching discrepancy as it is one of the most replicated effects
in preference elicitation literature.24–27 Some researchers have
tried to find arguments in favor of one method or the other.28
We believe that neither matching-based (like C-TTO) nor
TABLE 2. Estimation Results for Hybrid Model Using Main Effects Only
Hybrid (C-TTO+DC) Model C-TTO Model Rescaled DC Model
Coefficient SE P Coefficient SE P Coefficient SE P
MO1 0.084 0.008 0.000 0.015 0.015 0.293 0.088 0.010 0.000
MO2 0.014 0.009 0.101 0.053 0.015 0.000 0.012 0.011 0.272
MO3 0.130 0.010 0.000 0.152 0.018 0.000 0.115 0.012 0.000
MO4 0.060 0.010 0.000 0.023 0.019 0.230 0.081 0.013 0.000
SC1 0.056 0.008 0.000 0.038 0.015 0.009 0.030 0.011 0.008
SC2 0.000 0.009 0.989 0.001 0.017 0.964 0.017 0.011 0.126
SC3 0.097 0.011 0.000 0.131 0.020 0.000 0.079 0.013 0.000
SC4 0.016 0.009 0.090 0.012 0.018 0.506 0.022 0.011 0.047
UA1 0.053 0.008 0.000 0.040 0.014 0.006 0.037 0.011 0.000
UA2 0.005 0.010 0.572 0.035 0.019 0.069 0.008 0.011 0.485
UA3 0.072 0.010 0.000 0.085 0.021 0.000 0.069 0.011 0.000
UA4 0.004 0.010 0.705 0.030 0.017 0.082 0.024 0.013 0.056
PD1 0.078 0.008 0.000 0.049 0.014 0.000 0.066 0.011 0.000
PD2 0.024 0.009 0.007 0.044 0.019 0.024 0.019 0.012 0.093
PD3 0.115 0.011 0.000 0.100 0.019 0.000 0.130 0.013 0.000
PD4 0.105 0.010 0.000 0.090 0.023 0.000 0.118 0.014 0.000
AD1 0.085 0.008 0.000 0.057 0.018 0.002 0.065 0.011 0.000
AD2 0.044 0.010 0.000 0.038 0.018 0.040 0.049 0.012 0.000
AD3 0.121 0.010 0.000 0.116 0.019 0.000 0.119 0.013 0.000
AD4 0.053 0.010 0.000 0.049 0.017 0.005 0.063 0.013 0.000
Constant 0.007 0.004 0.087 0.098 0.018 0.000
LogL 10292.97 6565.7 3675.81
AIC 20631.95 13173.41 7391.62
BIC 20809.62 13324.25 7528.69
U(55555) 0.224 0.194 0.196
Lowest predicted value (state) 0.224 (55555) 0.224 (55455) 0.196 (55555)
Bold figures indicate logical inconsistencies.
MO, mobility; SC, self-care; UA, usual activities; PD, pain/discomfort; AD, anxiety/depression.
AIC indicates Akaike information criteria; BIC, Bayesian information criteria; C-TTO, composite time trade-off; DC, discrete choice.
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TABLE 4. Predicted Utility Values for Selected Health States for Estimated Models and From the Interim EQ-5D-3L Solution
State Hybrid ME Hybrid ME+D12+K452 Interim Solution From EQ-5D-3L
11112 0.9072 0.8945 0.9320
21111 0.9081 0.8877 0.8930
11121 0.9146 0.8958 0.9100
12111 0.9363 0.9207 0.8680
11211 0.9392 0.9190 0.9240
42114 0.4574 0.4259 0.4790
33511 0.7030 0.6342 0.2500
25331 0.5788 0.5418 0.1290
35411 0.5942 0.5265 0.1580
34511 0.6064 0.5383 0.2080
35412 0.5088 0.4676 0.1090
33531 0.6012 0.5541 0.1610
55512 0.3160 0.2747 0.2980
52533 0.2829 0.2822 0.2030
34544 0.1389 0.1716 0.0530
34553 0.1551 0.1541 0.1160
55433 0.1740 0.1817 0.3170
35552 0.1831 0.1738 0.2350
54454 0.1517 0.0777 0.3970
55444 0.0625 0.0045 0.4260
55552 0.0060 0.0057 0.5590
54455 0.2046 0.1391 0.4380
55554 0.1712 0.1134 0.6120
55545 0.1192 0.0689 0.5510
55555 0.2242 0.1748 0.654
ME indicates main effects.
TABLE 3. Estimation Results Using Best-fitted Model
Hybrid (C-TTO+DC) Model C-TTO Model Rescaled DC Model
Coefficient SE P Coefficient SE P Coefficient SE P
MO1 0.112 0.009 0.000 0.065 0.015 0.000 0.119 0.017 0.000
MO2 0.020 0.008 0.018 0.036 0.015 0.014 0.016 0.011 0.138
MO3 0.143 0.014 0.000 0.199 0.022 0.000 0.134 0.018 0.000
MO4 0.070 0.009 0.000 0.035 0.020 0.079 0.076 0.012 0.000
SC1 0.079 0.009 0.000 0.090 0.013 0.000 0.064 0.019 0.001
SC2 0.006 0.009 0.518 0.007 0.017 0.680 0.018 0.011 0.093
SC3 0.115 0.013 0.000 0.180 0.024 0.000 0.101 0.019 0.000
SC4 0.024 0.009 0.008 0.032 0.020 0.097 0.021 0.010 0.038
UA1 0.081 0.009 0.000 0.102 0.015 0.000 0.073 0.021 0.000
UA2 0.005 0.009 0.607 0.021 0.020 0.297 0.005 0.011 0.622
UA3 0.095 0.013 0.000 0.125 0.025 0.000 0.090 0.017 0.000
UA4 0.012 0.009 0.198 0.008 0.017 0.620 0.024 0.012 0.037
PD1 0.104 0.009 0.000 0.095 0.011 0.000 0.100 0.019 0.000
PD2 0.022 0.008 0.008 0.040 0.020 0.045 0.016 0.011 0.130
PD3 0.146 0.014 0.000 0.159 0.022 0.000 0.153 0.020 0.000
PD4 0.106 0.010 0.000 0.097 0.025 0.000 0.109 0.012 0.000
AD1 0.105 0.008 0.000 0.110 0.012 0.000 0.100 0.020 0.000
AD2 0.043 0.009 0.000 0.016 0.018 0.376 0.044 0.011 0.000
AD3 0.133 0.013 0.000 0.153 0.020 0.000 0.139 0.019 0.000
AD4 0.061 0.010 0.000 0.070 0.019 0.000 0.056 0.012 0.000
D12 0.009 0.001 0.000 0.013 0.003 0.000 0.007 0.003 0.020
K452 0.006 0.002 0.001 0.009 0.003 0.001 0.007 0.003 0.031
LogL 10247.2 6550.7 3670.1
AIC 20542.4 13145.3 7384.3
BIC 20727.8 13303.4 7535.1
Lowest predicted value (state) 0.175 (55555) 0.181 (55455) 0.160 (55555)
Bold figures indicate logical inconsistencies.
MO, mobility; SC, self-care; UA, usual activities; PD, pain/discomfort; AD, anxiety/depression.
AIC indicates Akaike information criteria; BIC, Bayesian information criteria; C-TTO, composite time trade-off; DC, discrete choice.
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choices (DC) methods are unbiased.29 Matching methods are
influenced by scale compatibility and, in the case of C-TTO,
by loss aversion.30 Choices are also subject to problems as it
has been shown that responses are more lexicographic in
choice than in matching. Evidence on the prominence effect
suggests that in choices, subjects tend to choose the alternative
that is better with respect to the more important attribute without
paying enough attention to how much better the option is.31
Finally, it has also been observed that subjects perceive the
distances between outcomes differently when comparisons are
conducted in a separate or in a joint model, again without clear
evidence that one method is better than another.32 We then do
not think that the “true” values can be inferred from 1 single
method and for this reason we suggest that it can make sense to
use a hybrid approach. We are not claiming that the biases
present in 1 method compensate the biases present in the other
so that adding up the 2 methods we get unbiased results. There
is no evidence to suggest this is the case. Even in the absence of
such empirical evidence, we think that there are reasons to
suspect that, at least, the potential biases present in the C-TTO
are not enhanced by choices of the DC experiment, rather the
opposite.
In our results, introducing the D12 and K452 terms
provided a better fit to the data suggesting that the selected
value set should have included such effect. However, the
improvement in fit is mostly captured by the C-TTO part of
the model. Given that the improvement in the goodness of fit
of using D12 and K452 variables was marginal as suggested
by the AIC and the BIC, we selected the main effects model
using the parsimony criterion.
As far as we are aware there is no EQ-5D-5L value set
available in the literature for direct comparison. Given the
lack of such information we compared our model with the
Spanish value set for the 3L version of EQ-5D.23 Our model
has higher values in the upper scale compared to the EQ-5D-
3L valuation study conducted in Spain. This was expected as
the label for level 2 in the 3L version is “some problems” and
the label for level 2 in the 5L version is “slight problems.”
However, the utility decrement of level 2 for AD dimension
is higher in our study than in the 3L study. A possible ex-
planation for this is the fact that the self-reported health
results in our sample showed a high rate of people reporting
problems in the AD dimension, causing them to put more
weight on this dimension in the valuation tasks. On the other
side of the scale the pits state prediction was higher in our
study. Something expected as well, as the change in the
wording of the mobility level “confined to bed” in EQ-5D-3L
to “unable to walk about” in EQ-5D-5L has changed the
definition of the worst possible health state. Given that this
new level is not as severe as “confined to bed” (which had the
largest decrement of all dimensions in the Spanish 3L study) it
is expected to obtain higher valuations for 55555 than for
33333. We observed a lower proportion of negative values in
our study in comparison with the Spanish EQ-5D-3L value set.
The number of nonextreme health states has increased >10-
fold in the EQ-5D-5L compared with the 3L version reducing
the proportion of the extreme health states, and partly ex-
plaining why the kernel density distribution of the 5L value set
shows a smaller area below 0 than the 3L value set.
The hybrid model is not exempt of limitations. The as-
sumption of normal distribution for the errors in the C-TTO part
suffers from problems related to the robustness of the estimation
of SE and related to the violation of the homoscedasticity
condition. In addition, the use of conditional logit model for DC
data does not explicitly consider within respondents correlations.
We try to limit the impact of these limitations by using cluster
estimations of the SEs of the estimated coefficients. However,
further exploration of more sophisticated hybrid models for both
types of data is needed. For example, the use of random co-
efficient models for the C-TTO part and mixed (conditional)
logit models for the DC part of the model.
We have observed significant differences in the valu-
ations observed by interviewers that lead us to be cautious
about suggesting a final value set to use in practice in Spain.
We are now trying to understand the nature of these differ-
ences, which could be attributable to several factors includ-
ing issues with the EQ-VT software, the use of C-TTO, or
noncompliance of the protocol by the interviewer.
We present here a novel methodological approach to
obtain an EQ-5D-5L value set. Our results show the feasi-
bility of using a hybrid model to estimate a value set for EQ-
5D-5L valuation data.
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APPENDIX: THE HYBRID MODEL
There are several methods that enable the combination
of both sets of data in a single model. The hybrid model we
present here uses a maximum likelihood approach. It builds
on the notion that both linear regression (as applied to the C-
TTO data) and logistic regression (as applied to the DC data)
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FIGURE 1. Probability density function of EQ-5D-3L and EQ-
5D-5L value sets.
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both models contain a similar linear component bx underlying
the values and choices. If one assumes that this component,
which reflects the weight given to the dimensions and labels, is
identical between both approaches, one can find the optimal
parameters for the combination of the data. This is done by
creating a single likelihood function for the joined data
by multiplying the likelihoods of the C-TTO data and the DC
data (or—equivalently—by adding the log likelihoods).
However, we know that the C-TTO model and the DC
model are anchored on a different scale. We can take this
into account in the combined likelihood by including an
additional parameter relating both linear functions with each
other. In the model presented here, we assume that the
weights (ie, the b’s) in both models differ up to a monotonic
transformation y.
The likelihood of the C-TTO data is expressed as
follows:






where bj is the vector of C-TTO regression coefficients, dij
the vector of dummy variables for state i, J the number of
dummies, and pdf the gaussian probability density function.















j is the vector of DC regression coefficients, d
A
ij the
vector of dummy variables for state A of pair i, dBij the vector
of dummy variables for state B of pair i, and cdf the Logit
cumulative density function.
Finally: Loglikehybrid¼ Log likeC-TTOlikeDCð Þ
¼ LoglikeC-TTOþLoglikeDC;
and the relation between b and b0 is assumed in the esti-
mation to be: yb0 = b.
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